226 related articles for article (PubMed ID: 24752265)
1. Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.
Peirano G; van der Bij AK; Freeman JL; Poirel L; Nordmann P; Costello M; Tchesnokova VL; Pitout JD
Antimicrob Agents Chemother; 2014 Jul; 58(7):3762-7. PubMed ID: 24752265
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage.
Peirano G; Pitout JD
Antimicrob Agents Chemother; 2014 May; 58(5):2699-703. PubMed ID: 24566175
[TBL] [Abstract][Full Text] [Related]
3. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
Price LB; Johnson JR; Aziz M; Clabots C; Johnston B; Tchesnokova V; Nordstrom L; Billig M; Chattopadhyay S; Stegger M; Andersen PS; Pearson T; Riddell K; Rogers P; Scholes D; Kahl B; Keim P; Sokurenko EV
mBio; 2013 Dec; 4(6):e00377-13. PubMed ID: 24345742
[TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum β-lactamase-producing Escherichia coli isolated from healthy humans in Mexico, including subclone ST131-B2-O25:H4-H30-Rx.
Cortés-Cortés G; Lozano-Zarain P; Torres C; Alonso CA; Ríos-Torres AM; Castañeda M; López-Pliego L; Navarro A; Del Carmen Rocha-Gracia R
J Glob Antimicrob Resist; 2017 Jun; 9():130-134. PubMed ID: 28552831
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6')Ib-cr Among Ciprofloxacin-Resistant
Alsharapy SA; Yanat B; Lopez-Cerero L; Nasher SS; Díaz-De-Alba P; Pascual Á; Rodríguez-Martínez JM; Touati A
Microb Drug Resist; 2018 Dec; 24(10):1537-1542. PubMed ID: 29883247
[No Abstract] [Full Text] [Related]
6. High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients.
Ho PL; Chu YP; Lo WU; Chow KH; Law PY; Tse CW; Ng TK; Cheng VC; Que TL
J Med Microbiol; 2015 Mar; 64(Pt 3):243-247. PubMed ID: 25587081
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
Hojabri Z; Mirmohammadkhani M; Kamali F; Ghassemi K; Taghavipour S; Pajand O
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
[TBL] [Abstract][Full Text] [Related]
8. Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.
Olesen B; Frimodt-Møller J; Leihof RF; Struve C; Johnston B; Hansen DS; Scheutz F; Krogfelt KA; Kuskowski MA; Clabots C; Johnson JR
Antimicrob Agents Chemother; 2014 Nov; 58(11):6886-95. PubMed ID: 25199783
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Characteristics of Sequence Type 131
Park JY; Yun KW; Choi EH; Lee HJ
Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
[No Abstract] [Full Text] [Related]
11. Prevalence of Quinolone Resistance of Extended-Spectrum β-Lactamase-Producing
Teramae M; Osawa K; Shigemura K; Kitagawa K; Shirakawa T; Fujisawa M; Miyara T
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635210
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of ESBL-Producing
Zendri F; Maciuca IE; Moon S; Jones PH; Wattret A; Jenkins R; Baxter A; Timofte D
Microb Drug Resist; 2020 Jun; 26(6):697-708. PubMed ID: 32519936
[TBL] [Abstract][Full Text] [Related]
13. Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.
Sauget M; Cholley P; Vannier A; Thouverez M; Nicolas-Chanoine MH; Hocquet D; Bertrand X
Int J Antimicrob Agents; 2016 Dec; 48(6):744-747. PubMed ID: 27836379
[TBL] [Abstract][Full Text] [Related]
14. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
Can F; Kurt-Azap Ö; İspir P; Nurtop E; Seref C; Loçlar İ; Aktaş ON; Orhan YC; Ergonul O
J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
[TBL] [Abstract][Full Text] [Related]
15. Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.
Birgy A; Levy C; Nicolas-Chanoine MH; Cointe A; Hobson CA; Magnan M; Bechet S; Bidet P; Cohen R; Bonacorsi S
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085515
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010.
Banerjee R; Robicsek A; Kuskowski MA; Porter S; Johnston BD; Sokurenko E; Tchesnokova V; Price LB; Johnson JR
Antimicrob Agents Chemother; 2013 Dec; 57(12):6385-8. PubMed ID: 24080662
[TBL] [Abstract][Full Text] [Related]
17. Adhesion and invasion to epithelial cells and motility of extended-spectrum β-lactamase-producing Escherichia coli reveal ST131 superiority: a comparative in vitro study of extraintestinal pathogenic E. coli lineages.
Kondratyeva K; Wollman A; Gerlitz G; Navon-Venezia S
J Med Microbiol; 2017 Sep; 66(9):1350-1357. PubMed ID: 28825894
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
Briales A; Rodríguez-Martínez JM; Velasco C; de Alba PD; Rodríguez-Baño J; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2012 May; 39(5):431-4. PubMed ID: 22365240
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea.
Kim SY; Park YJ; Johnson JR; Yu JK; Kim YK; Kim YS
Diagn Microbiol Infect Dis; 2016 Feb; 84(2):97-101. PubMed ID: 26643062
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Demirci-Duarte S; Unalan-Altintop T; Eser OK; Cakar A; Altun B; Sancak B; Gur D
Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115098. PubMed ID: 32603974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
